Industry officials, during a preliminary meeting Dec. 2 at Philadelphia Park, discussed testing for erythropoietin antibodies that could be implemented in Pennsylvania and perhaps a few other Mid-Atlantic states in 2004.
Though regulators on Dec. 10 will examine a proposal for a national medication and drug-testing policy, release of the document to the public hinges on how well it is received during the meeting.
The debate over whether Kentucky should implement a restrictive race-day medication policy heated up Nov. 18 with calls by racetrack veterinarians and trainers to keep the current policy intact, and allegations that the national Racing Medication and Testing Consortium is carrying out an agenda in secret.
The racing commissions that govern Thoroughbred and Standardbred racing in Delaware have been testing for erythropoietin antibodies since June 1, and in the future may implement rules to penalize horses that test positive.
New York regulators Oct. 21 gave final approval to a new rule authorizing the testing of post-race samples for performance-enhancing erythropoetin antibodies. The New York Racing and Wagering Board said the testing would begin Nov. 1, which would make New York the first state to require the test.
Oak Tree Racing Association has stepped up backstretch security for its current meet, which includes the Breeders' Cup World Thoroughbred Championships on Oct. 25 at Santa Anita Park.
The Kentucky Racing Commission has approved extensive drug testing in conjunction with the American Graded Stakes Committee mandate that it be implemented in order for stakes to retain their grades.
The chairman of the Kentucky Racing Commission has advocated a Salix-only policy on race day in the state, and said he would schedule meetings around the state to get feedback. Currently, five medications are permitted on race day in Kentucky.
The Racing Medication and Testing Consortium has made substantial progress on a model policy for the horse racing industry and also has allocated $275,000 for four research projects tied to its initiatives.
The Kentucky Racing Commission and the Kentucky Equine Drug Council in October will consider the mandate by the American Graded Stakes Committee that enhanced drug testing be implemented by next year in order for stakes to maintain their grades.
The Breeders' Cup board of directors on Monday officially endorsed the proposed Thoroughbred Championship Tour, and also said it would use a new drug-testing protocol being designed by the Thoroughbred Owners and Breeders Association for all graded stakes.
John Roark, president of the Texas Horsemen's Partnership and a board member of the National Thoroughbred Racing Association, fought back a challenge to win a second two-year term as president of the National Horsemen's Benevolent and Protective Association.
New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
With a goal to raise $2 million to $3 million a year to support its initiatives, the Racing Medication and Testing Consortium is looking at a mechanism that would raise money from horsemen and racetracks based on the top four finishers in each race.
Participants in a July 10 medication workshop reached the consensus that "over-medication" may contribute to fewer starts by racehorses, but other factors -- racetrack surfaces, an emphasis on speed, too much pressure on 2-year-olds, and a thirst for quick profit -- probably are just as responsible.
The board of directors of the Association of Racing Commissioners International will consider adoption of a policy that would make treatments such as hypoxic therapy prohibited practices until their impact on horses is scientifically demonstrated.
The American Graded Stakes Committee plans to install a drug testing protocol for all graded stakes in 2004 that will require laboratories to perform tests for approximately 140 parent drugs and their analytes.
The Kentucky Racing Commission has approved an agreement with the University of Kentucky for the college to apply for accreditation of its Animal Drug Testing Program and better monitor projects and control related costs.
Mid-Atlantic regulators and the Thoroughbred Horsemen's Association are scheduled to meet June 12 in New Jersey to discuss medication and drug-testing issues on a regional and national scope.
The American Graded Stakes Committee will begin implementing a drug-testing plan for horses participating in its designated races beginning at Keeneland and Belmont Park this fall. It expects to have the testing protocol fully in place by the end of 2004.
Say Florida Sandy, the all-time leading New York-bred in terms of earnings, has been placed first in the Jan. 25 Paumonok Handicap at Aqueduct because of the disqualification of Crossing Point for a clenbuterol positive after a post-race urine test.
The largest out-of-competition drug-testing raid in Australian history Monday at Randwick racecourse produced no positive tests. The practice was introduced in Australia last October.
Uniformity in medication and drug testing could be years away, a member of the Racing Medication and Testing Consortium said April 1 during a California Horse Racing Board Medication Committee meeting.
California has taken the first step to ban the backstretch use of snake venom, which officials believe can be used as a nerve- or joint-numbing agent in sore or injured horses.
The Thoroughbred Corp.'s Kafwain was disqualified from his second-place finish in the March 9 Louisiana Derby at Fair Grounds because he raced with an excessive amount of the bronchodilator clenbuterol. Trainer Bob Baffert did not appeal so Kafwain could make his next racing engagement, but he has called for uniformity in medication rules.
Four of five Standardbred trainers under investigation for illegally administering oxycodone to racehorses were exonerated when split samples showed no traces of the painkiller in urine taken from original samples that tested positive.
The chairman of the Kentucky Racing Commission says an investigation of a personal services contract awarded for a review of drug research is an attack on the racing commission and Thoroughbred industry in the state.
The first joint meeting of the boards of the Thoroughbred Racing Associations and Harness Tracks of America was considered a success, but whether the two organizations continue to meet jointly on a regular basis remains to be seen.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Kentucky officials will consider regulations for use of shock-wave therapy in racehorses and also whether money for equine drug research should be spent on establishing threshold levels and withdrawal times for permitted medications.
Two bills that would permit officials in Kentucky to spend money on equine drug research out of state were withdrawn from consideration in the state House of Representatives.
Antibodies for erythropoeitin, a blood-doping substance commonly known as EPO, were found in six racehorses at Sam Houston Race Park, the Dallas Morning News reported Feb. 18.
Aqueduct-based trainer Gary Contessa is awaiting his fate on a slew of ephedra positives that have sidetracked his operation.
The Racing Medication and Testing Consortium has elected officers, chosen an executive director, and put the finishing touches on few sections of its proposed model policy for medication and drug testing. Breeders' Cup president D.G. Van Clief Jr. was elected chairman.
The Racing Medication and Testing Consortium is scheduled to meet Feb. 4 in Atlanta, Ga., to hammer out details of its structure and further develop its policy statement.
The Kentucky Racing Commission has decided to form a committee to explore the testing of horses on days they're not scheduled to race. The decision stems from an earlier classification of erythropoeitin and the process of blood-doping as a prohibited practice.
Be My Royal, winner of the one the biggest races of the National Hunt season to date, faces disqualification in connection with a rash of positive drug tests for traces of morphine in British and Irish races due to contaminated feed.
The Kentucky Equine Drug Council will ask the Kentucky Racing Commission Jan. 15 to form a committee to tackle the complicated and controversial issue of out-of-competition testing.
The Texas Racing Commission has renewed its drug-testing contract with Texas Veterinary Medical Diagnostic Laboratory, and also approved some changes in the racing schedule at Manor Downs for 2003.
The Racehorse Medication and Testing Consortium formed earlier this year has incorporated as a charitable organization and issued its goals and objectives, one of which has been broadened to include the auction and training aspects of the Thoroughbred business.
The National Horsemen's Benevolent and Protective Association is prepared to release a revised proposal for a national policy on drug testing and therapeutic medication. The document deals with Class 1, 2, 3, and 4 medications, as well as prohibited practices.
The Thoroughbred Owners and Breeders Association, quite active on the racehorse medication front for the past few years, is advocating a plan to implement "super tests" for all graded stakes in the United States.
The Racing Medication and Testing Consortium is moving forward with a national policy statement and plans to incorporate.
Industry representatives in West Virginia met by teleconference Oct. 15 to devise emergency rules to govern use of adjunct bleeder medications and to ban the practice of blood-doping.
With no opposition in sight, the Kentucky Racing Commission on Sept. 24 officially revised its Thoroughbred race-day medication policy to reduce the number of permitted substances from 16 to five.
The Maryland Racing Commission has reduced the penalties of two trainers who had been dealt lengthy suspensions after their horses raced at Pimlico Race Course with an illegal drug in their systems.
The Kentucky Racing Commission, apparently at the urging of the state Equine Drug Council, has hired Dr. Richard Sams of Ohio State University to serve as a consultant on medication and drug-testing issues.
The chairman of the Kentucky Racing Commission said Sept. 13 he hopes a revised race-day medication policy for the Bluegrass state becomes a model for the rest of the country as it pushes toward uniformity in racehorse medication and drug testing.
Horsemen, veterinarians, racing officials, and regulators in Kentucky have been working behind the scenes to develop a new medication policy for the state that figures to greatly influence the debate over a uniform medication policy for the United States.
The Florida Division of Pari-Mutuel Wagering in August filed an administrative complaint against trainer Henry Collazo, alleging that a horse he ran at Calder Race Course tested positive for a derivative of morphine. The case has again put Florida's zero-tolerance policy under scrutiny.
Most Popular Stories
- Cigar Mile Stakes Card Fields Taking Shape
- Indiana Reports Multiple Medication Sanctions
- Wild Again Still Impacting the Breeders' Cup
- Ben's Cat Faces Tough Task in Fabulous Strike
- New Jersey to Press On for Sports Betting
- Suffolk Eyes Simulcast License for Next Year
- Monmouth, Atlantic City Granted 2015 Dates
- Moore, Ortiz Line Up for HK Jockey Battle
- Broadcaster Edwards to Emcee Eclipse Awards
- Goffs Registers Record-Breaking Foal Sale